| Literature DB >> 27000094 |
C J Bernstein1, D R Ellard2, G Davies3, E Hertenstein4, N K Y Tang5, M Underwood6, H Sandhu6.
Abstract
BACKGROUND: Primary dystonia is a chronic neurological movement disorder that causes abnormal muscle movements. Pain and emotional distress may accompany these physical symptoms. Behavioural interventions are used to help people with long term conditions improve their quality of life. Little is known about behavioural interventions applied to Dystonia. We report a systematic review of studies reporting current evidence of behavioural interventions for people with primary dystonia.Entities:
Keywords: Behavioural interventions; Idiopathic adult onset dystonia; Quality of life; Self-management
Mesh:
Year: 2016 PMID: 27000094 PMCID: PMC4802601 DOI: 10.1186/s12883-016-0562-y
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1List of review search terms
Fig. 2Flow diagram of screening and identification process [20]
Quality assessment summary
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|
| Bell and Thompson [ | Moderate | High | High | Moderate | Moderate | Unclear | Low |
| Bell et al. | Moderate | High | High | Moderate | Moderate | Unclear | High |
| Bell et al. [ | Low | High | High | Moderate | Low | Unclear | High |
| Boyce et al. [ | High | High | Moderate | Low | Moderate | Moderate | High |
| Cottraux et al. [ | High | High | High | High | High | Unclear | Low |
| Faircloth and Reid [ | Unclear | High | High | Moderate | Moderate | Unclear | Low |
| Greenberg [ | Unclear | High | High | Moderate | Moderate | Unclear | Low |
| Sharpe [ | Unclear | High | High | Unclear | High | Moderate | Unclear |
| Wieck et al. [ | High | Moderate | Moderate | Moderate | Moderate | Unclear | Moderate |
1. Diagnostic process-How well was the diagnostic process described?
2. Sample size-Is this defined?
3. Control group-Is a control group included and if so how well is it defined?
4. Physiological/psychological measure-To what extent are validated outcome measures described/used?
5. Description of intervention-How clear is the description of the intervention?
6. Medication-How well are the medications described?
7. Statistics-How appropriate is the statistical approach?
Low low risk of bias; moderate moderate risk of bias, high high risk of bias, unclear unclear risk of bias
Adapted from Hertenstein et al. [17]. See also web Appendix
Included studies basic characteristics and sample
| Citation | Setting (Country and location) | Design | Sample size (N=) | Mean age (Years) | Gender (m) (f) | Ethnicity | AAOa (Years) | MDb (Years) | PM/Tc |
|---|---|---|---|---|---|---|---|---|---|
| Bell and Thompson [ | Golf course | CS | 1 (case study) | 40y | 1 m | Caucasian/“White” | NR | 3y | NR |
| Bell et al. [ | USA, golf courses | CS |
| 51y | 3 m | Caucasian | NR | NR | NR |
| Bell et al. [ | USA, golf courses | CS |
| 51y | 4 m | Caucasian | NR | NR | NR |
| Boyce et al. [ | Australia, Physiotherapy out-patients clinic & and at home. | pRCT |
| 57.8y | 70 % f; 30 % m | NR | NR | 10.2y | Botulinum toxin therapy injections |
| Cottraux et al. [ | unspecified, | pRCT |
| 36y | 27 % f, 73 % m | NR | NR | 3.6y | psychotherapy |
| Faircloth and Reid [ | England, unspecified | CS | 1 | 36y | 1 m | NR | 26y | 10y | Botulinum Toxin therapy injections |
| Greenberg [ | England, London, participants’ homes | CLs | 4 | 52y | 25 % f; 75 % m | NR (1 said to be West Indian) | 49y | 3.5y | NR |
| Sharpe [ | Unspecified, hospital | CS | 1 | 51y | 1 m | NR | 50/51y | Around 11 months | ‘tetrabenazine and imipramine’ |
| Wieck et al. [ | London, England, Neurology clinic, participants’ homes | RCT |
| intervention group: 52y control group: 49y | 35 % f; 65 % m | NR | NR | Intervention 10y; control 13y | Psychotherapy, biofeedback and drugs. |
CS case studies, pRCT pilot randomised controlled trial, CLs clinical study, NR not reported, EMG electromyography
aAverage age of onset in years. bMean duration of condition, cPrevious medications/treatments
Included studies interventions
| Citation and conditiona | Intervention and control | Length of each treatment session (mins) | Frequency | Duration |
|---|---|---|---|---|
| Bell and Thompson [ | Intervention: SFGI protocol | 20–30 | 2x weekly | Unclear duration noted as a number of rounds of golf with follow-up |
| Bell et al. [ | Intervention: SFGI protocol | 20 | 2x weekly | Unclear duration noted as a number of rounds of golf with follow-up |
| Bell et al. [ | Intervention: SFGI protocol | 15 | 2x weekly (unclear) | Unclear duration noted as a number of rounds of golf with follow-up |
| Boyce et al. [ | Intervention: Exercise plus relaxation Control: Relaxation only | 30 (approx.) | 4x weekly for the first 4 weeks and then 8x ‘fortnightly for the following eight weeks’ | 8 sessions over 12 weeks |
| Cottraux et al. [ | Intervention: Multimodal behaviour therapy package with or without EMG feedback | 20 (EMG feedback) | 2x daily (without EMG feedback), | Average total = 14.7 sessions (time period unspecified) |
| Faircloth and Reid [ | Intervention: Cognitive Behavioural Therapy (CBT) approach adapting negative thoughts and beliefs into more productive thinking styles | Unspecified | Unspecified | ‘9 sessions lasting 10.5 h’ |
| Greenberg [ | Intervention: Habit reversal with awareness training, re-education and in vivo exposure. (included encouragement from family to practice) | Unclear (for one participant 1 h is reported) | Unspecified | Average total = 4 sessions over 5.5 h |
| Sharpe [ | Intervention: ‘Flexible behavioural therapy approach | 60 | Unspecified | Approx. 17 h over 14 weeks (1 week included in-patient treatment) |
| Wieck et al. [ | Intervention: Habit reversal (plus homework practice) | 90 | 5x monthly | 1 month |
EMG electromyography, SFGI solution focused guided imagery
a The identified studies examined different forms of the MDS idiopathic adult onset focal dystonia category
summary of outcome measures and findings for each identified study
| Citation and condition | Outcome measure(s) and timings | Procedure | Facilitator and evidence of facilitator training | Results & Adherence | Comments |
|---|---|---|---|---|---|
| Bell and Thompson [ | Yip frequency, baseline, during 5 rounds of golf and at a 60-day follow-up | Researcher read aloud the SGFI protocol to the participant prior to them putting. | Researcher (also, participant and playing partner recorded yip frequency and putting percentage) | Exposure to the SFGI reduced yip frequency from an average of 9.2 yips per round to 0.2 yips per round. | There was no control group to compare the findings, although the authors note that ‘each participant serves as their own control as participants’ performance is compared across baseline and intervention phases’ The study recruited only one participant and so no statistical power, generalisability or reliability. |
| Bell et al. [ | Yip occurrences were observed at baseline, during at least 5 treatment sessions of golf and at a 3-week follow-up golfing session after the last SFGI round. | 1-2 independent observers were stationed at each site. The primary researcher read aloud the SFGI protocol to participants prior to them putting. | Primary researcher (also, 3 trained observers recorded putting behaviour and yip frequency) | Participant 1, BL yips 4, Reduced to 1.4, FU NR | It is unclear whether the primary researcher was 1 of the 3 trained observers. Training provision was specified for the 3 observers but not for the primary researcher. |
| Bell et al. [ | Yip frequency was measured at baseline, immediately after treatment and at follow-up (12–14 weeks post-treatment). | Individual/1 facilitator read aloud the SGFI protocol to each participant and then recorded the participant’s answers 15 min prior to them putting. | Trained facilitators (individual/1 facilitator per participant). | 100 % of participants showed a decrease in the frequency of yip behaviour: | The study is underpowered because it reports on only 4 participants. |
| Boyce et al. [ | Baseline (week 0), during treatment (week 6), post-treatment (week 12) and at a 4-week follow-up (week 16). | Intervention: | Physiotherapist (individual/supervised physiotherapy sessions) | No adverse effects reported. Mild muscle soreness was reported in 66 % of the sample. | Small sample and effect size. |
| Cottraux et al. [ | Writing quality was observed at baseline (pre)-intervention), post-intervention (last session) and follow-up (at varying weeks between 1 to 9 months). | ‘Relaxation, and/or systematic desensitisation (SD), and/or assertiveness training through role playing were combined with Electromyography (EMG) feedback’ (2 participants were not given EMG feedback) (P. 182) | Unspecified but participants were referred to authors’ department | 69 % of the sample ( | Small sample size. |
| Faircloth and Reid [ | Measures were conducted at baseline (pre-treatment), post-treatment and at one, three and six month follow-ups. | Enabling self-focus, generating adaptive beliefs and challenging negative thinking. | Unspecified | Improvements were noted in psychological well-being (i.e., anxiety and depression). Pain and discomfort in the participant’s neck was reported as less severe. All of the participant’s 6 months follow-up scores were lower than at baseline. | Small study ( |
| Greenberg [ | Measures were conducted at baseline (pre-treatment), 1 month, 6 months and various time periods between 2 and 6 years. | A combination of ‘habit reversal, in vivo exposure and re-education’ [apart from 1 participant] Awareness training, encouragement from relatives and homework practice were also given. | Nurse therapists, | The treatment showed an improvement in writing skills at least until the 6-months follow-up phase (p. 297). | Small sample size. |
| Sharpe [ | Unspecified, baseline, treatment and 9 months follow-up | Relaxation (exercise) training for the eyelids, learning not to force the eyelids open and seeking rewarding reinforcements for keeping the eyelids open | Unspecified | Outcomes included reduction of eyelid spasm and ache as well as relaxation of the eyelids. | Small study ( |
| Wieck et al. [ | Outcome measures were recorded at baseline (pre-treatment, weeks 0 and 4), post-treatment (week 8) and at a 3 months follow-up (week 20). | Patients were educated to know when their symptoms were triggered and to immediately respond (e.g., by putting down the pen) until their cramp stopped. Severer participants were asked to draw lines proceeding to more complex shapes and finally, words. | 2 therapists | No significant differences were reported between the intervention and control groups on 89 % of the measures. | Small sample size. |
Criteria for quality assessment
| Risk of bias rating | ||||
|---|---|---|---|---|
| Low | Moderate | High | Unclear | |
| Diagnostic process | Diagnosis according to established, published criteria | Diagnostic process is described in sufficient detail, but no published criteria were used | Authors mention who performed the diagnosis (e.g., experienced movement specialists) but do not describe the diagnostic process itself | Diagnostic process not described |
| Sample size | ≥ 100 per group (sufficient to detect an effect of Cohen‘s d=0.35) | 21-99 per group | < 20 per group (not sufficient to detect a sample size of Cohen‘s d = 0.8) | Sample size not mentioned |
| Control group | Healthy controls matched for age and sex | Unmatched healthy controls, matched only for age or only for sex, historical control group, controls with another disorder but no healthy controls | No control group | Not mentioned whether control group was included |
| Physiological/ psychological measure | Valid physiological and/or psychological measures of subjective | One adequate physiological and/or psychological measure (for example clinician ratings of dystonia severity according to validated scale and/or psychological wellbeing | Unvalidated subjective and/or objective measures, questionnaire insensitive or otherwise inappropriate | Measures not sufficiently described |
| Description of intervention | An adequate, clear and comprehensive description of the intervention is provided, including the following: what is being tested, theoretical framework underlying the intervention, components of the intervention, how it was delivered and by whom, what research methods were employed, analytical techniques, when and where it was delivered, whether any materials were used and a description of any relevant facilitator/researcher training | Partially full descriptions of the intervention are provided (i.e. between 1-5 components of this criterion lack sufficient detail or are not provided but the remaining 6-11 components are described in detail) | Very few details are given about how the intervention was delivered (e.g. between 1-5 components of this criterion are adequately described but the remaining 6-11 are not described in detail and/or missing) or otherwise inappropriate or irrelevant descriptions are provided | None of the criterion’s components are described |
| Medication | Un-medicated sample | Medicated sample, medication reported in detail | Medicated sample, medication insufficiently described | Medication not described |
| Statistics | Analysis/statistical approach is adequate for design and sample size, conditions for use of statistical approach tested and described in sufficient detail | Minor shortcomings leading to imprecision, but not invalidation of the results, e.g. conditions for use of statistical approach not tested or not described | Major shortcomings, e.g. no significance testing, inappropriate statistical procedure | Statistical approach not sufficiently described |
Adapted from Hertenstein et al. [18]